(Q54674351)

2 June 2018

title

Sensitivity to rifampicin: incidence, mechanism, and prevention. (English)

1 reference

2 June 2018

1 reference

Pujet JC

1

1 reference

2 June 2018

Homberg JC

series ordinal

2

1 reference

2 June 2018

Decroix G

series ordinal

3

1 reference

2 June 2018

language of work or name

English

0 references

publication date

1 May 1974

1 reference

2 June 2018

published in

The BMJ

1 reference

2 June 2018

volume

2

1 reference

2 June 2018

issue

5916

1 reference

2 June 2018

page(s)

415-418

1 reference

2 June 2018

Study of an allergic antibody active in the presence of sodium p-aminosalicylate (PAS) against human erythrocytes, leukocytes and platelets

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1610485

Haemolytic anaemia in the rabbit following the injection of human anti-I cold agglutinins

4 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1610485

Potentially Serious Side Effects of High-dose Twice-weekly Rifampicin

4 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1610485

Systemic collateral effects of intermittent antituberculous treatments with rifampicin

4 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1610485

Recurrent hemolytic accidents of immuno-allergic origin during intermittent treatment with rifampicin

4 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1610485

Acute kidney failure due to rifampicin

4 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1610485

Intermittent Therapy with Rifampin Once a Week in Advanced Pulmonary Tuberculosis

4 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1610485

Acute renal failure after rifampicin

4 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1610485

Rifampicin: initial study of plasma levels during prolonged treatment of pulmonary tuberculosis patients

4 June 2018

1 reference

12 December 2020

Rifampicin-induced immune thrombocytopenia

1 reference

12 December 2020

Comparative study of the treatment of pulmonary tuberculosis by a combination of rifampicin and isoniazid administered daily and twice weekly for a year

1 reference

12 December 2020

Hemolytic crisis due to rifampicin

1 reference

12 December 2020

Adverse reactions to daily and intermittent rifampicin regimens for pulmonary tuberculosis in Hong Kong

1 reference

12 December 2020

[Liver tolerance of antitubercular treatment including rifampicin. Study on 214 cases]

1 reference

12 December 2020

Identifiers

DOI

10.1136/BMJ.2.5916.415

1 reference

2 June 2018

PMC publication ID

1610485

1 reference

2 June 2018

PubMed publication ID

4835299

1 reference

2 June 2018